Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship of chemerin with nutritional status and appetitive traits in early childhood: a cross-sectional study.

European journal of pediatrics·2026
Same author

No Regression With Imatinib Treatment for Craniofacial Fibrous Dysplasia Associated With McCune-Albright Syndrome.

Journal of pediatric hematology/oncology·2025
Same author

Concerns for mood disorders in children presenting with early menarche is not an indication for pubertal suppression.

Journal of pediatric endocrinology & metabolism : JPEM·2025
Same author

Final Adult Height in Girls Treated with GnRH Analogues for Precocious Puberty Around Age Eight.

Children (Basel, Switzerland)·2025
Same author

Comparison of the clinical characteristics of children with Silver-Russell syndrome genetically confirmed or not and their response to growth hormone therapy: a national multicenter study.

Journal of pediatric endocrinology & metabolism : JPEM·2025
Same author

Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration.

Nature communications·2025

Related Experiment Video

Updated: Jun 7, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Trace elements in obese Turkish children.

Mehmet Emre Tascilar1, Ilker Tolga Ozgen, Ayhan Abaci

  • 1Department of Pediatrics, Gulhane Military Medical Academy, Ankara, Turkey.

Biological Trace Element Research
|October 20, 2010
PubMed
Summary

Obese children exhibit poor diet quality, potentially impacting micronutrient status. This study found lower serum vanadium and cobalt levels in obese Turkish children compared to healthy controls, suggesting a role in obesity pathogenesis.

More Related Videos

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

Related Experiment Videos

Last Updated: Jun 7, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children
04:55

Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

Published on: September 11, 2018

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Environmental Health

Background:

  • Obesity in children is a growing concern with potential links to dietary habits and micronutrient status.
  • Altered eating patterns in obese individuals may affect essential trace element levels.
  • Understanding micronutrient profiles is crucial for addressing pediatric obesity.

Purpose of the Study:

  • To investigate serum trace element levels in obese Turkish children.
  • To compare the levels of 19 trace elements between obese children and healthy controls.
  • To explore potential associations between trace element status and childhood obesity.

Main Methods:

  • Serum samples were collected from 34 obese children and 33 healthy controls.
  • Levels of 19 trace elements (including selenium, zinc, vanadium, cobalt, etc.) were measured.
  • Statistical analysis was performed to compare element levels between the two groups.

Main Results:

  • Obese children showed significantly lower serum vanadium levels compared to controls (0.244 ± 0.0179 vs. 0.261 ± 0.012 μg/l, p < 0.001).
  • Serum cobalt levels were also significantly lower in obese children than in controls (0.14 ± 0.13 vs. 0.24 ± 0.15 μg/l, p = 0.011).
  • No significant differences were observed for other measured trace elements.

Conclusions:

  • Serum vanadium and cobalt levels may be altered in obese children.
  • These alterations in trace element status could play a role in the pathogenesis of childhood obesity.
  • Further research is warranted to confirm these findings and elucidate the mechanisms involved.